<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Sodium acetate: Drug information</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Sodium acetate: Drug information</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="drugTitle">Sodium acetate: Drug information</div><div class="clear"></div><div id="topicText"><div class="visuallyHidden drugH1Div" id="formulinkBodyPlaceholder"><span class="drugH1"></span></div>
(For additional information <a class="drug drug_patient" data-topicid="12119" href="/d/html/12119.html" rel="external">see "Sodium acetate: Patient drug information"</a> and <a class="drug drug_pediatric" data-topicid="12793" href="/d/html/12793.html" rel="external">see "Sodium acetate: Pediatric drug information"</a>)<br/><br/>For abbreviations, symbols, and age group definitions used in Lexicomp (<a class="graphic graphic_table" href="/d/html/57469.html" rel="external">show table</a>)<div class="ex_sect_xr thclist drugH1Div drugBrandNames" id="F221569"><span class="drugH1">Pharmacologic Category</span>
<ul>
<li>
                        Electrolyte Supplement, Parenteral</li></ul></div>
<div class="block doa drugH1Div" id="F221563"><span class="drugH1">Dosing: Adult</span>
<p style="text-indent:-2em;margin-left:2em;">
<b>Note:</b> Sodium acetate is metabolized to bicarbonate on an equimolar basis outside the liver; administer in large volume IV fluids as a sodium source. Refer to Sodium Bicarbonate monograph.</p>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="970e87e9-581e-444a-8c60-bba3a8d4ce08">Maintenance electrolyte requirements of sodium in parenteral nutrition solutions</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Maintenance electrolyte requirements of <span style="text-decoration: underline">sodium</span> in parenteral nutrition solutions:</b></p>
<p style="text-indent:-2em;margin-left:4em;">
<b>
<i>
<span style="text-decoration: underline">Acetate maintenance</span></i></b>
<b>
<i> electrolyte requirement:</i></b> IV: Acetate and chloride content should be adjusted to maintain acid-base balance with parenteral nutrition; use equal amounts of acetate and chloride and adjust ratio based on individual patient needs (Mirtallo 2004).</p>
<p style="text-indent:-2em;margin-left:4em;">
<b>
<i>
<span style="text-decoration: underline">Sodium maintenance</span></i></b>
<b>
<i> electrolyte requirement (combination of chloride and acetate, where applicable): </i></b>IV: 1 to 2 mEq/kg/24 hours; customize amounts based on individual patient needs (Mirtallo 2004). General maximum sodium acetate: 100 to 150 mEq/24 hours.</p></div>
</div>
</div>
<div class="block dora drugH1Div" id="F50990753"><span class="drugH1">Dosing: Kidney Impairment: Adult</span>
<p style="text-indent:0em;display:inline">No dosage adjustment provided in manufacturer’s labeling. Use with caution.</p></div>
<div class="block doha drugH1Div" id="F50988135"><span class="drugH1">Dosing: Hepatic Impairment: Adult</span>
<p style="text-indent:0em;display:inline">No dosage adjustment provided in manufacturer’s labeling. Use with caution.</p></div>
<div class="block doe drugH1Div" id="F221564"><span class="drugH1">Dosing: Older Adult</span>
<p style="text-indent:0em;display:inline">Refer to adult dosing.</p></div>
<div class="block dop drugH1Div" id="F2871758"><span class="drugH1">Dosing: Pediatric</span><p>(For additional information <a class="drug drug_pediatric" data-topicid="12793" href="/d/html/12793.html" rel="external">see "Sodium acetate: Pediatric drug information"</a>)</p>
<p style="text-indent:0em;display:inline">
<b>Note</b>
<b>:</b> Maintenance sodium should be incorporated into the patient's maintenance IV fluids; acid/base balance should be considered when selecting a sodium salt; acetate is converted to bicarbonate on an equimolar basis within the body and may affect serum pH.</p>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="715ebaee-9d35-4a16-a367-3057526d40f4">Parenteral nutrition, maintenance sodium requirement</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Parenteral nutrition, maintenance sodium requirement:</b>
<b>Note:</b> A combination of salt forms may be necessary to fulfill sodium requirement (ASPEN [Mirtallo 2004]).</p>
<p style="text-indent:-2em;margin-left:4em;">Infants and Children ≤50 kg: IV: 2 to 5 mEq/kg/day of sodium as an additive to parenteral nutrition solution.</p>
<p style="text-indent:-2em;margin-left:4em;">Children &gt;50 kg and Adolescents: IV: 1 to 2 mEq/kg/day of sodium as an additive to parenteral nutrition solution.</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="d73b4940-94c8-457d-b8da-b428566ee843">Metabolic acidosis</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Metabolic acidosis</b>: Limited data available: Infants, Children, and Adolescents: Each mEq of acetate is converted 1:1 to mEq of bicarbonate (HCO<sub>3</sub>
<sup>-</sup>); dosage should be based on standard dosing formulas if blood gases and pH measurements are available. Refer to the Sodium Bicarbonate monograph for specific dosing details and equations.</p></div>
</div>
</div>
<div class="block dorp drugH1Div" id="F51160093"><span class="drugH1">Dosing: Kidney Impairment: Pediatric</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in manufacturer’s labeling. Use with caution.</p></div>
<div class="block dohp drugH1Div" id="F51160094"><span class="drugH1">Dosing: Hepatic Impairment: Pediatric</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in manufacturer’s labeling. Use with caution.</p></div>
<div class="block adr drugH1Div" id="F221550"><span class="drugH1">Adverse Reactions</span>
<p style="text-indent:0em;display:inline">The following adverse drug reactions and incidences are derived from product labeling unless otherwise specified.</p>
<p style="text-indent:0em;">1% to 10%:</p>
<p style="text-indent:-2em;margin-left:2em;">Cardiovascular: Localized phlebitis, thrombosis</p>
<p style="text-indent:-2em;margin-left:2em;">Endocrine &amp; metabolic: Electrolyte disturbance (dilution of serum electrolytes), hypernatremia, hypervolemia, hypocalcemia, hypokalemia, metabolic alkalosis, water intoxication</p>
<p style="text-indent:-2em;margin-left:2em;">Gastrointestinal: Abdominal distention, flatulence</p>
<p style="text-indent:-2em;margin-left:2em;">Respiratory: Pulmonary edema</p></div>
<div class="block coi drugH1Div" id="F221558"><span class="drugH1">Contraindications</span>
<p style="text-indent:0em;display:inline">Hypernatremia and fluid retention</p></div>
<div class="block war drugH1Div" id="F221548"><span class="drugH1">Warnings/Precautions</span>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>
<i>Concerns related to adverse effects:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">• Hypernatremia: Close monitoring of serum sodium concentrations is needed to avoid hypernatremia.</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>
<i>Disease-related concerns:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">• Acid/base disorders: Use with caution in patients with acid/base alterations; contains acetate, monitor closely during acid/base correction.</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">• Edema: Use with caution in edematous patients.</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">• Heart failure (HF): Use extreme caution in patients with HF; monitor closely for edema.</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">• Hepatic impairment: Use with caution in patients with severe hepatic impairment.</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">• Renal impairment: Use with caution in patients with renal impairment; monitor serum sodium concentrations closely.</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>
<i>Dosage form specific issues:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">• Aluminum: The parenteral product may contain aluminum; toxic aluminum concentrations may be seen with high doses, prolonged use, or renal dysfunction. Premature neonates are at higher risk due to immature renal function and aluminum intake from other parenteral sources. Parenteral aluminum exposure of &gt;4 to 5 mcg/kg/day is associated with CNS and bone toxicity; tissue loading may occur at lower doses (Federal Register, 2002). See manufacturer’s labeling.</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>
<i>Other warnings/precautions:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">• Extravasation: Avoid extravasation.</p></div>
<div class="block foc drugH1Div" id="F221554"><span class="drugH1">Dosage Forms: US</span>
<p style="text-indent:0em;text-align:justify;display:inline">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Solution, Intravenous, as anhydrous: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Generic: 2 mEq/mL (20 mL, 50 mL, 100 mL); 4 mEq/mL (50 mL, 100 mL)</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Solution, Intravenous, as anhydrous [preservative free]: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Generic: 2 mEq/mL (50 mL, 100 mL); 4 mEq/mL (100 mL)</p></div>
<div class="block geq drugH1Div" id="F221545"><span class="drugH1">Generic Equivalent Available: US</span>
<p style="text-indent:0em;display:inline">Yes</p></div>
<div class="block fee drugH1Div" id="F16323860"><span class="drugH1">Pricing: US</span>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Solution</b> (Sodium Acetate Intravenous)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">2 mEq/mL (per mL): $0.11 - $0.44</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">4 mEq/mL (per mL): $0.11 - $0.41</p>
<p style="text-indent:0em;">
<b>Disclaimer: </b>A representative AWP (Average Wholesale Price) price or price range is provided as reference price only. A range is provided when more than one manufacturer's AWP price is available and uses the low and high price reported by the manufacturers to determine the range. The pricing data should be used for benchmarking purposes only, and as such should not be used alone to set or adjudicate any prices for reimbursement or purchasing functions or considered to be an exact price for a single product and/or manufacturer.  Medi-Span expressly disclaims all warranties of any kind or nature, whether express or implied, and assumes no liability with respect to accuracy of price or price range data published in its solutions.  In no event shall Medi-Span be liable for special, indirect, incidental, or consequential damages arising from use of price or price range data.  Pricing data is updated monthly.</p></div>
<div class="block dinfoc drugH1Div" id="F52868254"><span class="drugH1">Dosage Forms: Canada</span>
<p style="text-indent:0em;text-align:justify;display:inline">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Solution, Intravenous, as anhydrous: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Generic: 4 mEq/mL (50 mL, 100 mL)</p></div>
<div class="block adm drugH1Div" id="F221556"><span class="drugH1">Administration: Adult</span>
<p style="text-indent:0em;display:inline">IV: Must be diluted prior to IV administration; infuse hypertonic solutions (eg, &gt;2.8% sodium acetate in sterile water [2.8% sodium acetate in sterile water has osmolarity approximately equivalent to 2% sodium chloride]) via a central line (Mortimer, 2006; Suarez, 2004). If diluted in D<sub>5</sub>W or other solution, the osmolarity may be higher requiring central line administration at a lower sodium acetate concentration.</p>
<p style="text-indent:0em;margin-top:2em;">Consult individual institutional policies and procedures.</p></div>
<div class="block admp drugH1Div" id="F52613861"><span class="drugH1">Administration: Pediatric</span>
<p style="text-indent:0em;display:inline">Parenteral: Must be diluted prior to IV administration; dose and rate of administration are dependent on patient condition. Consult individual institutional policies and procedures; in general, central-line administration is preferred for hypertonic solutions (&gt;0.9%) if available and/or if infusion is to be continued; peripheral administration may be necessary for initiation of treatment in critical patients; use of peripheral administration should be limited (Luu 2011). Some suggest central line administration is not needed until infusing solutions &gt;2.8% sodium acetate in sterile water (2.8% sodium acetate in sterile water has osmolarity approximately equivalent to 2% sodium chloride) (Mortimer 2006; Suarez 2004). If diluted in D5W or other solution, the osmolarity may be higher requiring central line administration at a lower sodium acetate concentration.</p></div>
<div class="block use drugH1Div" id="F221555"><span class="drugH1">Use: Labeled Indications</span>
<p style="text-indent:0em;display:inline">Sodium source in large volume IV fluids to prevent or correct hyponatremia in patients with restricted intake; used to counter acidosis through conversion to bicarbonate</p></div>
<div class="block mst drugH1Div" id="F27999827"><span class="drugH1">Medication Safety Issues</span>
<div class="collapsible">
<span class="collapsible-title">Sound-alike/look-alike issues: </span>
<div class="collapsible-wrap">
<p style="text-indent:-2em;margin-left:4em;">Sodium acetate may be confused with potassium acetate</p></div>
</div>
</div>
<div class="block cyt drugH1Div" id="F13300048"><span class="drugH1">Metabolism/Transport Effects</span>
<p style="text-indent:0em;display:inline">None known.</p></div>
<div class="block dri drugH1Div" id="F6222956"><span class="drugH1">Drug Interactions</span>
<br/><br/><div class="clear"></div><p style="text-indent:0em;display:inline">There are no known significant interactions.</p></div>
<div class="block pri drugH1Div" id="F13888238"><span class="drugH1">Pregnancy Considerations</span>
<p style="text-indent:0em;display:inline">Animal reproduction studies have not been conducted. Sodium requirements do not change during pregnancy (IOM, 2004).</p></div>
<div class="block brc drugH1Div" id="F13888239"><span class="drugH1">Breastfeeding Considerations</span>
<p style="text-indent:0em;display:inline">Sodium is found in breast milk. Sodium requirements do not change during lactation (IOM, 2004).</p></div>
<div class="block dic drugH1Div" id="F221559"><span class="drugH1">Dietary Considerations</span>
<p style="text-indent:0em;display:inline">Sodium acetate anhydrous (2 mEq/mL): 1 mL = 164 mg sodium acetate anhydrous = 2 mEq of sodium (46 mg) and acetate (118 mg) </p></div>
<div class="block mop drugH1Div" id="F54372354"><span class="drugH1">Monitoring Parameters</span>
<p style="text-indent:0em;display:inline">Serum electrolytes, including sodium, calcium, serum pH.</p></div>
<div class="list fbnlist drugH1Div drugBrandNames" id="F58197660"><span class="drugH1">Brand Names: International</span><div class="ibn-search drugBrandNames"></div>
<div class="collapsible-indication brand-names-accordion drugBrandNames"><span class="collapsible-indication-title">International Brand Names by Country</span><div class="collapsible-indication-wrap-frame drugBrandNames"><div class="collapsible-indication-wrap drugBrandNames">For country code abbreviations (<a class="graphic graphic_table" href="/d/html/116421.html" rel="external">show table</a>)<br xmlns=""/><br/><ul>
<li>
<span class="countryCode">(BR)</span> <span class="country">Brazil</span><span class="countrySeparator">: </span><span class="drugName">Acetato de sodio</span>;</li>
<li>
<span class="countryCode">(ES)</span> <span class="country">Spain</span><span class="countrySeparator">: </span><span class="drugName">Acetato sodico Fresenius Kabi</span>;</li>
<li>
<span class="countryCode">(FI)</span> <span class="country">Finland</span><span class="countrySeparator">: </span><span class="drugName">Fysioring</span>;</li>
<li>
<span class="countryCode">(MX)</span> <span class="country">Mexico</span><span class="countrySeparator">: </span><span class="drugName">Solucion ac s pisa</span>;</li>
<li>
<span class="countryCode">(PE)</span> <span class="country">Peru</span><span class="countrySeparator">: </span><span class="drugName">Acetosodium</span></li></ul></div>
</div>
</div>
</div>
</div><div class="headingAnchor" id="references"><ol id="reference">
<li>
<div class="reference">
                  Aluminum in large and small volume parenterals used in total parenteral nutrition. <i>Fed Regist</i>. 2002;67(244):77792-77793. To be codified at 21 CFR §201.323.</div>
</li>
<li>
<div class="reference">
                  IOM (Institute of Medicine), <i>Dietary Reference Intakes for Water, Potassium, Sodium, Chloride, and Sulfate</i>, Washington, DC: National Academy Press, 2004.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-22134236">
<a name="22134236"></a>Luu JL, Wendtland CL, Gross MF, et al. Three-percent saline administration during pediatric critical care transport. <i>Pediatr Emerg Care</i>. 2011;27(12):1113-1117.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-acetate-drug-information/abstract-text/22134236/pubmed" id="22134236" target="_blank">22134236</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-15568296">
<a name="15568296"></a>Mirtallo J, Canada T, Johnson D, et al. Safe practices for parenteral nutrition. <i>JPEN J Parenter Enteral Nutr</i>. 2004;28(6):S39-S70.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-acetate-drug-information/abstract-text/15568296/pubmed" id="15568296" target="_blank">15568296</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-16817665">
<a name="16817665"></a>Mortimer DS, Jancik J. Administering hypertonic saline to patients with severe traumatic brain injury. <i>J Neurosci Nurs</i>. 2006;38(3):142-146.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-acetate-drug-information/abstract-text/16817665/pubmed" id="16817665" target="_blank">16817665</a>]</span>
</div>
</li>
<li>
<div class="reference">
                  Sodium acetate [prescribing information]. Wixom, MI: Woodward Pharma Services LLC; May 2020.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-14964472">
<a name="14964472"></a>Suarez, JI. Hypertonic saline for cerebral edema and elevated intracranial pressure.<i>Cleve Clin J Med</i>. 2004;71 Suppl 1:S9-13.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-acetate-drug-information/abstract-text/14964472/pubmed" id="14964472" target="_blank">14964472</a>]</span>
</div>
</li></ol></div><div id="topicVersionRevision">Topic 9926 Version 178.0</div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
